Abstract: Fatty liver disease is characterized histologically by hepatic steatosis, the abnormal accumulation of lipid in hepatocytes. It is classified into alcoholic fatty liver disease and nonalcoholic fatty liver disease, and is an increasingly important cause of chronic liver disease and cirrhosis. Assessing the severity of hepatic steatosis in these conditions is important for diagnostic and prognostic purposes, as hepatic steatosis is potentially reversible if diagnosed early. The criterion standard for assessing hepatic steatosis is liver biopsy, which is limited by sampling error, its invasive nature, and associated morbidity. As such, noninvasive imaging-based methods of assessing hepatic steatosis are needed. Ultrasound and computed tomography are able to suggest the presence of hepatic steatosis based on imaging features, but are unable to accurately quantify hepatic fat content. Since Dixon's seminal work in 1984, magnetic resonance imaging has been used to compute the signal fat fraction from chemical shift-encoded imaging, commonly implemented as out-of-phase and in-phase imaging. However, signal fat fraction is confounded by several factors that limit its accuracy and reproducibility. Recently, advanced chemical shift-encoded magnetic resonance imaging methods have been developed that address these confounders and are able to measure the proton density fat fraction, a standardized, accurate, and reproducible biomarker of fat content. The use of these methods in the liver, as well as in other abdominal organs such as the pancreas, adrenal glands, and adipose tissue will be discussed in this review.
M
agnetic resonance imaging (MRI) has been used historically to detect and qualitatively assess the presence and degree of fat accumulation in the liver as well as the presence of fat in the adrenal glands, other organs, and fat-containing lesions. 1, 2 Recently, advanced chemical shift-encoded (CSE) methods have been developed that can quantify the proton density fat fraction (PDFF) in the liver as an accurate and precise biomarker of hepatic steatosis. [3] [4] [5] [6] [7] This biomarker has been studied extensively in recent years as an objective indicator for the presence and degree of liver fat accumulation, and it is now being used in clinical care and in clinical trials as an eligibility marker and study end point. [8] [9] [10] Advanced CSE methods are now being applied in investigational studies to assess PDFF in the pancreas but are not yet validated for this purpose. 11 Although CSE has been used to identify the presence of fat in the adrenal glands to characterize adrenal nodules and differentiate lipidrich adenomas from metastases, PDFF has not been investigated as a quantitative imaging biomarker of adrenal fat yet. [12] [13] [14] [15] In addition to quantifying fractional fat content in solid organs, MRI has also been used to quantify whole body fat volume. [16] [17] [18] [19] [20] [21] [22] [23] However, most MRI techniques for this purpose have relied on manual segmentation, which is expensive, laborious, and impractical, limiting their use to small cohorts in the research setting. 19, [24] [25] [26] Recently, a technique based on 3D Dixon imaging has been proposed to quantify intra-abdominal adipose tissue as well as subcutaneous adipose tissue. The new method enables faster fat quantification and its large-scale feasibility has been demonstrated in the United Kingdom BioBank study. 23, 27 In this article, we review advanced PDFF quantification methods for the liver and the scientific evidence supporting their use. We also briefly review their applications beyond the liver including quantification of fractional fat content in the pancreas and adrenals, and computation of adipose tissue volumes.
FAT QUANTIFICATION IN THE LIVER Signal Fat Fraction Using Fat-suppressed Techniques
Fat-suppression techniques quantify liver fat by acquiring 2 images, 1 with and 1 without a fat-saturation pulse. Applying chemical fat-saturation pulse sequences decreases the overall signal intensity in the liver by suppressing the signal attributable to fat. The image acquired with fat saturation represents water signal only, whereas that acquired without fat saturation represents the sum of fat and water signals. The fat signal is computed by subtracting signal intensities from the 2 sets of images, and the signal fat fraction is then calculated as the signal from fat divided by the combined signal from fat and water. This technique has been available since the 1990s, and in 1 study, was shown to correlate better with histological steatosis grade than conventional dual in-phase (IP) and out-of-phase (OP) imaging for assessing hepatic steatosis. 28, 29 However, since complete suppression of fat signal is not possible (due to B 0 magnetic field inhomogeneity), the water image is invariably contaminated by fat signal, which causes unavoidable errors in fat quantification. Fatsuppressed techniques are thus not suitable for PDFF measurement.
Signal Fat Fraction Using Chemical Shift-encoded and Magnetic Resonance Spectroscopy Techniques
Since 1984, when Thomas Dixon published his seminal paper, the fat signal fraction has been calculated using CSE methods 30 by separating the MR signal into its water and fat components. There are 2 main CSE approaches: the magnitude-based approach, which uses only magnitude data without the phase data, and the complex-based approach which uses both magnitude and phase data. The former magnitude-based method acquires images at 2 or more echo times, ideally where the water peak and the dominant fat peak are nominally IP and OP. 31 The signal fat fraction is the difference between the IP and OP signal intensities divided by double the IP signal intensity. Using the IP and OP data permits computation of the proportion of the dominant signal; however, due to fat/water signal dominance ambiguity, the range of measurable signal fat fractions is 0% to 50%. The complex-based approach requires at least 3 echoes, with optimal separation between echoes of 2p/3, and the middle echo being centered at p/2 þ pk, where k is an integer. 32 The use of magnitude and phase data together permits unambiguous separation of fat and water signals, allowing measurement of the signal fat fraction over a range of 0% to 100%. With either approach, the fat signal fraction is the signal from fat divided by the combined signal from fat and water.
In MR spectroscopy (MRS), data are generally acquired from a single anatomical location (referred to as the MRS voxel), and proton signal intensities from fat and water can be measured from the chemical peaks of their proton moieties. The relative contributions from fat and water can be quantified directly from the areas under their corresponding peaks in the acquired spectrum, and the fat fraction calculated.
The fat signal fraction is independent of radiofrequency coil sensitivity and B 0 magnetic field inhomogeneity, and-for MRI approaches-requires only a single breath-hold for entire liver coverage. However, the fat signal fraction can be confounded by a number of factors, including T1-weighting bias, T2 or T2 Ã signal decay, the multipeak spectral complexity of fat, noise bias, J-coupling effects, and eddy currents. 31, 33 Importantly, for many of these factors, the magnitude of the introduced errors depends on the individual scanner, scanner field strength, acquisition parameters, and biological factors such as iron overload. This means that fat signal fraction measurements are neither accurate nor reproducible. This limits their utility for clinical care and research, and prevents reliable pooling of results in meta-analyses.
Proton Density Fat Fraction Using Chemical Shiftencoded and Magnetic Resonance Spectroscopy Techniques
To accurately and reproducibly quantify fat content, advanced CSE MRI and MRS techniques have been developed to measure PDFF by addressing the factors that confound fat signal fraction estimation (Table 1) . Below, we describe how these confounding factors are addressed, how the images are acquired, and how PDFF is calculated.
Accounting for Confounders
T1 bias refers to the phenomenon in which increased T1 weighting causes amplification of signal from fat relative to water, because fat has shorter T1 time than water. Because the T1 time of water can be 2 or 3 times greater than that of fat, this bias causes PDFF overestimation. T1 bias can be addressed by using a long repetition time (TR) or a low flip angle in spoiled gradient echo acquisitions, leading to a proton density-weighted acquisition. However, using a low flip angle reduces the signal-to-noise ratio (SNR). T1 bias may also be addressed by optimizing the flip angle (based on the Ernst angle) to maximize SNR and performing a T1-signal correction, which requires an additional acquisition to perform T1 mapping. T1 bias can also affect MRS and is usually minimized by using a long TR and minimum mixing time.
T2 Ã decay causes increasing signal loss with increasing echo times after the initial radiofrequency excitation, leading to incorrect estimation of the water and fat signal amplitudes. T2
Ã signal decay is accelerated by the presence of excess liver iron, which may occur in patients with fatty liver disease. If not corrected for, T2
Ã decay results in fat content underestimation (if the first OP echo time is shorter than the first IP echo time) or overestimation (if the first OP echo time is longer than the first IP echo time). The magnitude of the error depends on the degree of iron overload as well as other factors, and so is difficult to predict. Advanced techniques address this confounding effect by acquiring at least 3 adequately spaced echoes and incorporating the time-dependent signal decay into the signal model as 1/T2 Ã (R2 Ã ). [33] [34] [35] Inclusion of this parameter reduces SNR but is necessary for accurate PDFF estimation. In most implementations, fat and water are modeled to have the same T2 Ã values (as opposed to modeling separate T2 Ã values), which is a reasonable compromise between PDFF accuracy, SNR, and modeling simplicity. In addition, 1 group found that modeling the T2 Ã values of fat and water had no significant effect on PDFF values overall, but created noisier PDFF maps. 36 For MRS, T2 decay needs to be taken into account when modeling observed fat and water signal intensities back to their proton density-weighted signals. The T2 of fat and water can be modeled separately, but all fat peaks are assumed to have the same T2 relaxation time.
The concept of calculating the fat signal fraction with OP and IP imaging assumes that water and fat can each be described as a single resonance frequency whose relative signal intensities oscillate at regular periods. Although this assumption is true for the water peak, it is not true for the fat peak, since hydrogen protons in the triglyceride molecule resonate at different frequencies depending on their exact positions within the triglyceride molecule; each position is associated with different electron shielding effects. For this reason, the fat spectrum consists of multiple peaks, the signals of which interfere with each other as well as with water. Because of this complex interference pattern, water and fat are never exactly OP and IP and signal fat fraction calculations based on a simplistic OP and IP model are intrinsically incorrect (Fig. 1) . The errors introduced by the multifrequency effects of fat can be addressed by using a spectral model that specifies the chemical shifts and relative amplitudes of each fat peak derived from spectroscopic data by Hamilton et al. 37 It has been shown that the use of a multipeak spectral model improves the accuracy of PDFF estimation. [38] [39] [40] Several slightly different spectral models have been proposed, with no particular model being shown to outperform any other. 41 For MRS, although most of the spectrum can be observed, some portions of fat peak overlap with the water peak and cannot be visualized directly; accurate measurement of these peaks requires spectral modeling based on prior knowledge of the typical human triglyceride structure.
Noise bias results during the recombination of separated water and fat images into a fat-fraction image. It occurs because areas of low signal have only positive noise after the magnitude operation, and is thus most pronounced at low fat fractions. Noise bias can be mitigated by magnitude discrimination and phase-constrained reconstruction. 42 Eddy currents generated during rapid switching of magnetic gradients result in inaccurate phase data, which affects complexbased methods. This may be addressed with hybrid approaches, by acquiring additional calibration data, or by calculating and removing concomitant gradient effects. 31 In MRS, the hydrogen nuclei which are close to one another in a triglyceride molecule can affect each others' effective magnetic fields. This phenomenon is termed J-coupling and effects fat peaks in a TE-dependent manner, resulting in a biased T2 estimation and PDFF estimation when using MRS. This may be minimized by 
acquiring spectra at relatively short TEs. J-coupling of fat peaks is not a significant confounder for most CSE MRI techniques that use low flip angle spoiled gradient echo sequences, but it may affect techniques that use fast spin-echo sequences. 31 Acquisition, Reconstruction, and Postprocessing for Chemical Shift-encoded Techniques PDFF measurement is based on gradient-echo sequences, with magnitude-based approaches typically based on 2D gradient-echo imaging and complex-based approaches typically based on 3D gradient-echo imaging. 31 These methods have been validated at both 1.5 and 3 T.
4,5 A low flip angle and long TR are used to minimize the confounding effects of T1 weighting. Six echoes are typically collected to perform signal fitting to estimate T2 Ã decay, although the use of as few as 3 and as many as 16 echoes have been described. 43 In one study of magnitude-based techniques, accuracy relative to MR spectroscopy decreased with increasing numbers of echoes, presumably due to noise floor effects and/or modeling imperfections. 43 The fat fraction is computed on a per-voxel basis to generate PDFF maps (Fig. 2) .
Comparison of Magnitude-based and Complex-based Chemical Shift-encoded Techniques
Magnitude-based and complex-based techniques each have their own respective advantages and disadvantages. One advantage of magnitude-based techniques is greater availability, as the acquisition can be reproduced easily using standard available pulse sequences on many commercial MR scanners, though off-line processing may be necessary. Complex-based techniques are now available as commercial product sequences, but generally require purchase as add-ons, which has hampered their clinical adoption.
Because magnitude-based techniques do not use phase data, they are more robust to the confounding effects of eddy currents, which preferentially affect the accuracy of the phase data. In addition, by using a single amplitude value instead of the separate real and imaginary data components, these components are effectively averaged, which increases the signal-to-noise ratio. 33 Conversely, by discarding phase data, magnitude-based techniques can only achieve a dynamic range of 0% to 50% due to fat-water signal ambiguity (Fig. 2) . Complex-based techniques can achieve the full dynamic range of 0% to 100% through incorporation of phase data (Fig. 2) . The assumption that water is the dominant signal is rarely violated in the assessment of hepatic steatosis, even in severe cases, but may not suffice when assessing tissues such as bone marrow or adipose tissue where fat is the dominant signal.
The lack of complete fat-water separation also implies that magnitude-based techniques cannot be used for fat-suppression imaging. 44 Magnitude images exhibit Rician distributions rather than Gaussian distributions, which creates a so-called ''noise floor.'' 33 These noise floor effects introduce greater bias in magnitude-based reconstructions, which becomes particularly prominent at lower fat fraction ranges and high T2 Ã signal decay rates (such as in severe iron overload) where the signal-to-noise ratio is low. 45 
Magnetic Resonance Spectroscopy
As with MRI-based quantification techniques, confounding factors must be accounted for in MR spectroscopy to compute PDFF rather than the fat signal fraction. . The red curve represents the simulated signal interference pattern of fat and water where fat is simplistically modeled as a single peak at 1.3 ppm. The superimposed blue curve represents the simulated signal interference pattern between fat and water where fat is modeled more realistically as 6 separate peaks, each with its own chemical shift and relative amplitude as described in the text.
Two main types of MRS sequence are typical used for PDFF estimation: stimulated echo acquisition mode (STEAM) and point resolved spectroscopy (PRESS). For both, a single voxel (typically 2 Â 2 Â 2 cm 3 ) is placed in liver parenchyma, using images to avoid liver edges, large vessels, and large bile ducts. Spectra are generally acquired in a single breath-hold with no spatial or chemical saturation, and a long TR (>3000 ms) is used to minimize T1 weighting. To correct for T2 decay, signals are either acquired at a single short TE and corrected with predefined water and fat T2 values, or they acquired at multiple TEs to calculate T2-corrected peak areas of water and fat (Fig. 3) . STEAM is preferred to PRESS because STEAM is capable of shorter minimum TE than PRESS. The shorter TE of STEAM also minimizes the confounding effects of J-coupling.
The fat signal fraction can be computed from the relative areas under the peaks corresponding to fat and water. Two of the fat peaks cannot be easily distinguished from the water peak, and their contribution to the water peak is corrected using a previously derived liver spectrum. Because of its high sensitivity and accuracy, MRS has been used as a reference standard for a number of studies, which have validated the accuracy of MRI-based PDFF. 4, 5, 36, 39, [46] [47] [48] [49] [50] In some cases, MRS has been used for direct PDFF measurement as a biomarker of hepatic steatosis. 8, 51, 52 MRS has also been demonstrated to have high reproducibility. 53 One of the disadvantages of MRS is that PDFF is only measured in a single anatomical location and analysis is complicated. In addition, analysis of the collected spectrum must be performed offline and requires specialized skills and software. MRS has not been widely used clinically because of the necessary postprocessing and the lack of anatomical information.
Computed Tomography and Ultrasound
On noncontrast computed tomography (CT), the normal liver has slightly lower attenuation than the spleen and blood vessels. 54 Increasing fat content results in even lower attenuation of the liver, which can be assessed relative to the spleen and quantified as an attenuation difference in Hounsfield units (HU). Hepatic steatosis may be diagnosed if the attenuation of the liver is at least 10 HU less than that of the spleen. 55 Hepatic steatosis may also be diagnosed if the absolute attenuation of the liver is less than 40 to 50 HU 56, 57 or if the unenhanced liver is lower in attenuation than the intrahepatic blood vessels (Fig. 4) . However, precise thresholds for making the diagnosis of steatosis vary from study to study. On contrast-enhanced CT examinations, the assessment of hepatic steatosis is dependent on the rate of contrast injection as well as the scan timing, making it a difficult tool to use in a standardized manner. 58, 59 In 1 study, the qualitative assessment of hepatic steatosis on contrast-enhanced CT was highly specific, however had low sensitivity. 60 Although a practical tool for diagnosis of hepatic steatosis, CT is unable to quantitatively assess fat fraction accurately and precisely.
Similarly, the diagnosis of hepatic steatosis may be made on conventional ultrasound but cannot be assessed quantitatively (Fig. 5) . On ultrasound, hepatic steatosis is assessed qualitatively using a combination of imaging features such as liver-kidney contrast, vessel blurring, posterior beam attenuation, focal fat sparing, and gallbladder and diaphragm visualization. 61, 62 Ultrasonographic assessment of hepatic steatosis is limited by its low sensitivity and accuracy, 63, 64 especially at lower steatosis grades, 65, 66 and substantial interobserver variability. 67 Although hepatic steatosis may be assessed on ultrasound examinations performed for other clinical indications, it is not the diagnostic test of choice. 68 On ultrasound transient elastography, the controlled attenuation parameter may be able to more quantitatively assess the degree of steatosis; however, it has an unacceptably high technical failure rate of 8% to 35% in patients with nonalcoholic fatty liver disease. [69] [70] [71] Hepatic steatosis may also be assessed using quantitative ultrasound techniques, which compute the backscatter coefficient. [72] [73] [74] FIGURE 3. MR spectrum using the STEAM sequence from the liver of the same 44-year-old female at the location demarcated in Figure 2 . The water peak (W) is at 4.7 ppm. The 6 fat peaks (1-6) are at 5.3, 4.2, 2.75, 2.1, 1.3, and 0.9 ppm. Spectra were collected at 5 echo times ranging from 10 to 30 ms, allowing measurement of and correction for T2 decay. The estimated PDFF by MRS was 38.1%. Quantitative ultrasound may be more accurate than conventional ultrasound, but has not been widely studied to date. 75 
FAT QUANTIFICATION IN THE PANCREAS
Pancreatic fat has been quantified using a variety of MRbased techniques, including 2-point Dixon, 3-point Dixon, complex-based CSE-MRI, and MRS in various clinical studies 49,76 -80 It has been shown that fat in the pancreas tends to be evenly distributed and increases with age. 76 The severity of pancreatic steatosis is associated with the severity of hepatic steatosis, 77 and it is also associated with increasing BMI and decreased insulin secretion. 79 In one study of complex-based CSE-MRI, it was found that the correlation between MRI and MRS was weaker in the pancreas than in the liver. 49 This may be due to the smaller size of the pancreas and signal contamination from surrounding visceral fat in the MRS voxel.
Pancreatic fat may also be assessed using CT. In one study, which quantified pancreatic steatosis by comparing pancreatic attenuation to splenic attenuation, the CT attenuation indices were associated with histological steatosis grade and impaired glucose metabolism. 81 However, this has not been further studied to date.
FAT QUANTIFICATION IN THE ADRENAL GLANDS
Detection of fat in the adrenal glands is important for distinguishing adrenal adenomas, which often contain fat, from malignant tumors.
12,14 However, there is not an obvious clinical need for the quantification of fat in the adrenal glands. Some investigations have been published using dual-energy CT 82 and double-echo CSE-MRI 83 for fat quantification in the adrenals for the abovementioned purpose; however, reasonable performance for the diagnosis of lipid-rich adenomas is achievable with qualitative assessment of fat content using MRI.
FAT QUANTIFICATION IN ADIPOSE TISSUES
In addition to quantifying the fractional fat content in solid organs such as the liver, MRI has been used to quantify the volume of abdominal adipose tissue compartments. 19, 24 Traditional MRI methods for quantifying adipose tissue volume were based on manual segmentation, which is expensive, laborious, and impractical for research studies and clinical practice. This has limited their use to a small number of image slices in the research setting, but numerous automated and semiautomated methods have been developed for adipose and muscle tissue segmentation recently. 23 One of these techniques has recently been implemented in the United Kingdom BioBank study of more than 3000 adults, which demonstrates its large-scale feasibility. 27 These methods face 2 main challenges in binary tissue classification and 2D segmentation. The binary classification of each voxel as either strictly adipose or nonadipose tissue leads to underestimation of fat volume at tissue interfaces where subvoxel fat is not included in the estimated fat volume because the whole voxel is classified as nonadipose tissue. 84, 85 2D segmentation separates fat tissues on each individual slice without incorporating information from neighboring slices, resulting in segmentation errors that are more pronounced in morphologically complex fat structures or in the presence of imaging artifacts.
CONCLUSIONS
MR-based techniques for fat quantification include imaging with and without fat saturation, CSE imaging, and MRS. Ultrasound and CT allow qualitative assessment of fat content in the liver but do not provide accurate fat quantification. The advent of advanced CSE techniques that account for confounders of signal fat fraction has enabled the computation of PDFF, an accurate and reproducible imaging biomarker of fat content in tissues. PDFF quantification may use a magnitude-based approach, which is based on MR magnitude data, or can use a complex-based approach, which uses both the magnitude data and phase data. The main application of these techniques in the abdomen are for the assessment of hepatic steatosis, where liver biopsy is currently the criterion standard for hepatic steatosis but is limited by sampling error and its invasive nature. These CSE techniques are also applicable to other abdominal organs/ tissues such as the pancreas, adrenal glands, and adipose tissues, but are not as well investigated for these applications. The liver is noticeably more echogenic than the kidney. Also notice posterior beam attenuation with poor visibility of the diaphragm, as well as poor visibility of intrahepatic blood vessels. Together, these qualitative features indicate hepatic steatosis. Although these conventional sonographic findings indicate steatosis, they do not permit accurate or precise quantification of fat content.
